ArticlePharmaceutical research2009

Cell type-specific targeting with surface-engineered lentiviral vectors co-displaying OKT3 antibody and fusogenic molecule.

Haiguang Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.